Drug
Lusutrombopag
Lusutrombopag: highest development phase Phase 3, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lusutrombopag NCT02389621 | Phase 3 | Chronic Liver Disease |
Latest
No recent events.
Follow Lusutrombopag on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.